This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 28| Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
|---|---|---|---|---|---|---|---|---|---|
| 2074 | 3-Hydroxyanthranilic acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
| 2088 | Aspartate aminotransferase to white blood cell count ratio (AWR) | Others | Human | AWR > 5.2 was an adverse predictor of DFS and OS in HCC after hepatectomy | Prognostic | HCC patients with AWR >5.2 v/s HCC patients with AWR <5.2; predict survival of patients | p < 0.01 | Blood | 27057915 |
| 2269 | Phosphoserine aminotransferase | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 3.8) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2278 | Cyclophilin B (Peptidyl-prolyl cis-trans isomerase B) | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.53) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2286 | Glutamine amidotransferase | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.69) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2333 | RAN | RNAs | Human | Upregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
| 2379 | Alanine:glyoxylate aminotransferase | RNAs | Human | Upregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
| 2386 | Transferrin | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
| 2397 | Acyl-coenzyme A:cholesterol acyltransferase 1 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
| 2399 | CTP:phosphocholinecytidyl transferase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
| 2410 | Glutathione S-transferase θ1 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
| 2411 | Glutathione S-transferase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
| 2412 | Glutathione S-transferase M3 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
| 2413 | Glutathione S-transferase θ2 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
| 2468 | hnRNP K, HSP70RY, Lamin B1, 40S ribosomal protein SA, FTCD, SOD, Arginase, SMP-30, P5C dehydrogenase, Transitional endoplasmic reticulum ATPase, Ubiquitin carboxyl-terminal hydrolase 5, Thiosulfate sulfurtransferase (Rhodanese), Betaine-himocysteine S-methyltransferase, NCC27, FGB, RACK1, PDI, SARDH | Protein | Human | Differentially expressed (hnRNP K, HSP70 RY, Lamin B1, 40S ribosomal protein SA, Transitional endoplasmic reticulum ATPase, Ubiquitin carboxyl-terminal hydrolase 5, Rhodanese, Betaine-himocysteine S-methyltransferase, NCC27, Fibrinogen β chain, RACK1 are Upregulated and rest 12 are Downregulated) | Diagnostic | HBV associated HCC tumor v/s non-tumorous | p < 0.05 | Tissue | 14654528 |
| 2496 | Guanidinoacetate N-methyltransferase | Protein | Human | Downregulated in HCC than non tumor (with mean ratio of nearly 5.3 +/- 8.6) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 12481271 |
| 2497 | Catechol O-methyltransferase | Protein | Human | Downregulated in HCC than non tumor (with mean ratio of nearly 3.2 +/- 3.8) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 12481271 |
| 2504 | CDC28 protein kinase2, CDC27HS protein, Integrin beta 4, Desmoplakin 1/2, Procollagen C proteinase, platelet derived growth factor, cytidine deaminase, aminoacyalse1, Betaine homocysteine S-methyltransferase, methylenetetrahydrofolate dehydrogease, metalloproteinase inhibitor1, aldehyde oxidase, met | RNAs | Human | Diffrenetially expressed in HCV and HBV associated HCC v/s non-tumor | Diagnostic | HCV and HBV associated HCC v/s non-tumor | p < 0.01 | Tissue | 11973655 |
| 2505 | Lactate dehydrogenase, aldehyde oxidase, nucleoside diphosphate kinase, alpha 1 catenin, beta catenin, transforming protein rho B, IgG, IgGK, IgG3, IgG1, IgG1K, IgA1, IgHA, IgG1-Fc, Collagen - alpha 1 subunit, c-jun N-terminal kinase 2, ADP/ATP carrier protein, Progression receptor associated protei | RNAs | Human | Diffrenetially expressed in cirrhotic v/s non-cirrhotic | Diagnostic | cirrhotic v/s non-cirrhotic | p < 0.01 | Tissue | 11973655 |
| 2506 | Zinc finger protein, integrin alpha 6, hepatoma derived growth factor, TGF beta induced, Macrophage inhibitory cytokine 1, lymphocyte antigen, aldehyde oxidase, c-myc purine binding transcription factor puf, plasminogen, vitronectin, hemoglobin alpha subunit, cytosolic superoxide dismutase, methylen | RNAs | Human | Diffrenetially expressed in moderately differentiated HCC v/s poorly differentiated HCC | Diagnostic | moderately differentiated HCC v/s poorly differentiated HCC | p < 0.01 | Tissue | 11973655 |
| 2525 | Cytoplasmic dynein light chain, Hepatoma-derived growth factor, Ribosomal protein L6, glutathioneS-transferase, Fibronectin, Ras homolog gene family member B, TR3 orphan receptor, c-myc transcription factor (puf), MHC-class IC | RNAs | Human | Upregulated in HCC than non-tumorous tissue ( with average ratio more than 2) | Diagnostic | HCC v/s non-tumor | NA | Tissue | 11283847 |
| 2527 | transgelin 2 | RNAs | Human | Upregulated in HCC than non-tumorous tissue | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15756260 |
| 2551 | Isocitrate dehydrogenase [NADP] (cytoplasmic), Fumarate hydratase (mitochondrial), Enoyl-CoA hydratase (mitochondrial), Betaine-homocysteine S-methyltransferase, Serotransferrin precursor | Protein | Human | Downregulated in well-differentiated HCC (with 2 fold change) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15852300 |
| 2553 | Keratin type I cytoskeletal 10, Catalase, Aldehyde dehydrogenase (mitochondrial), GlutathioneS-transferase A1, Antioxidant protein 2, Isocitrate dehydrogenase [NADP] (cytoplasmic), Formiminotransferase-cyclodeaminase, Carbonic anhydrase I, Fructose bisphosphate aldolase B, Arginase 1, Fructose-1, 6- | Protein | Human | Downregulated in poorly-differentiated HCC (with 2 fold change) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15852300 |
| 2554 | sterol-C5-desaturase, Peroxisomal phytanoyl-CoA alpha-hydroxylase, Homo sapiens clone 23915, Osteopontin 5/6 0, Full-length cDNA clone ZD66D02, Senescence-associated epithelial membrane protein(SEMP1), Human DNA topoisomerase II (top2) mRNA, Homo sapiens lysosomal membrane glycoprotein-2 (LAMP2), Hu | RNAs | Human | Upregulated in HCC than non-tumor | Diagnostic | Tumor v/s normal | NA | Tissue | 12136251 |
| 2562 | galectin-3,serine/threonine kinase, translation factor eIF- 4A, -4B, -3, fibroblast growth factor receptor, and ri- bosomal protein L35A | RNAs | Human | Upregulated in HCC | Diagnostic | HCC v/s non-tumor | Tissue | 12521301 | |
| 2580 | Dystrophin, Homolog to tubulin beta chain, Zinc finger protein 337, Friedreich ataxia region gene X123, Fibronectin (Alt. Splice 1), Zinc finger protein 9, Metallothionein IV, Poly(rC) binding protein 3, KIAA0426 gene product, Hypothetical protein FLJ13910, RAN binding protein 2 like 1, S100 calcium | RNAs | Human | Downregulated in L1 than L0 (with fisher ratio more than 9.74) | Prognostic | non-tumorous livers L1 (with HCV infection) v/s and L0 (without HCV infection) ; associated with invasion or metastsis | P = 0.001 | Tissue | 15710396 |
| 2581 | Cystatin C, Prolylcarboxypeptidase (angiotensinase C), Lysyl-tRNA synthetase, Voltage-dependent anion channel 3, Protective protein for beta-galactosidase (cathepsin A), Interferon gamma-inducible protein 30, Signal sequence receptor delta, Thioredoxin-related transmembrane protein, Cathepsin D, Ras | RNAs | Human | Upregulated in L1 than L0 (with Fisher ratio more than 8.9) | Prognostic | non-tumorous livers L1 (with HCV infection) v/s and L0 (without HCV infection) ; associated with invasion or metastsis | P = 0.001 | Tissue | 15710396 |